mtraore – Page 14

14/09/2016 : Theradiag carries out a capital increase fully subscribed by its Chinese partner HOB Biotech

Post author:mtraore
Post published:14 September 2016
Post category:Press Releases

Croissy-Beaubourg and Montpellier, September 14, 2016 – Theradiag (ISIN: FR0004197747, Ticker: ALTER, eligible for PEA-PME plans), a company specializing in in vitro diagnostics and theranostics, is today announcing that it carried out a capital increase fully…

05/09/2016 : LISA TRACKER® chosen by Janssen Biotech for its program to monitor patients treated with Remicade® in the USA

Post author:mtraore
Post published:5 September 2016
Post category:Press Releases

Croissy-Beaubourg and Montpellier, September 5, 2016 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER, PEA-PME eligible), a company specialized in in vitro diagnostics and theranostics, reports that, on August 29, Janssen Biotech Inc. announced the launch of a…

11/07/2016 : Vincent Fert appointed to Theradiag’s Board of Directors

Post author:mtraore
Post published:11 July 2016
Post category:Press Releases

Croissy-Beaubourg and Montpellier, July 11, 2016 – THERADIAG (ISIN: FR0004197747, Ticker: ALTER, PEA-PME eligible), a company specializing in in vitro diagnostics and theranostics, is today announcing Vincent Fert’s appointment to the Company’s Board of Directors.Vincent Fert…